Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Egetis Therapeutics - Filing #701621

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
104 542 SEK
178 024 SEK
Revenue
38 243 SEK
40 662 SEK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
130 110 SEK
134 639 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
5 957 SEK
59 543 SEK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
8 902 SEK
228 405 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.